BG 378: Psilocybin: A Crash Course in Mindfulness

Episode Description:

Roland Griffiths is the lead investigator of the Psilocybin Research Initiative at Johns Hopkins and one of the United States’ leading psychopharmacologists. In the conclusion to his conversation with host Vincent Horn, Roland provides more details on the Hopkins Meditation Study, Vincent shares his personal story of psychedelic experimentation, and they discuss the risks and benefits of mixing meditation practice with the psilocybin experience.

This is part two of a two part series.

Listen to part one BG 377: Meditating on Mushrooms.

Episode Links:


Roland Griffiths

Forty years after the Nixon administration effectively shut down research on psychedelic drugs, Roland Griffiths helped reopen it. One of the nation’s leading psychopharmacologists, Griffiths’ research focuses on the behavioral and subjective effects of mood-altering drugs. He is the lead investigator of the Psilocybin Research Initiative at Johns Hopkins, which includes studies of psilocybin occasioned mystical experience in healthy volunteers and cancer patients, and a pilot study of psilocybin-facilitated smoking cessation. Roland is a Professor in the Departments of Psychiatry and Neurosciences at the Johns Hopkins University School of Medicine. He has been a consultant to the National Institutes of Health, and to numerous pharmaceutical companies in the development of new psychotropic drugs.

Website: Roland R. Griffiths, Ph.D.